Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$44.2 - $50.2 $22,453 - $25,501
-508 Reduced 3.66%
13,380 $609,000
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $825,460 - $1.74 Million
-25,909 Reduced 65.1%
13,888 $602,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $1.11 Million - $1.82 Million
-24,525 Reduced 38.13%
39,797 $2.62 Million
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $25 Million - $48.9 Million
-604,175 Reduced 90.38%
64,322 $2.9 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $6 Million - $9.38 Million
-82,963 Reduced 11.04%
668,497 $48.3 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $4.66 Million - $6.09 Million
53,420 Added 7.65%
751,460 $80.6 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $3.34 Million - $4.42 Million
35,480 Added 5.35%
698,040 $77.4 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $209,367 - $243,511
1,751 Added 0.26%
662,560 $84.8 Million
Q3 2021

Nov 03, 2021

BUY
$109.17 - $142.35 $1.7 Million - $2.22 Million
15,585 Added 2.42%
660,809 $87.9 Million
Q2 2021

Aug 12, 2021

BUY
$100.34 - $115.69 $5.06 Million - $5.84 Million
50,448 Added 8.48%
645,224 $69.8 Million
Q1 2021

May 13, 2021

SELL
$101.51 - $125.27 $4.57 Million - $5.64 Million
-45,049 Reduced 7.04%
594,776 $62.6 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $4.59 Million - $5.64 Million
-53,496 Reduced 7.72%
639,825 $66.6 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $2.15 Million - $2.73 Million
-29,506 Reduced 4.08%
693,321 $59.4 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $8.26 Million - $13.6 Million
-172,063 Reduced 19.23%
722,827 $53 Million
Q1 2020

May 14, 2020

SELL
$36.95 - $62.95 $1.42 Million - $2.42 Million
-38,435 Reduced 4.12%
894,890 $46.5 Million
Q4 2019

Feb 11, 2020

BUY
$47.06 - $56.64 $218,405 - $262,866
4,641 Added 0.5%
933,325 $52.5 Million
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $7.3 Million - $8.93 Million
153,865 Added 19.86%
928,684 $44.3 Million
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $839,889 - $1.16 Million
21,393 Added 2.84%
774,819 $0
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $3.23 Million - $4.76 Million
108,266 Added 16.78%
753,426 $0
Q4 2018

Feb 15, 2019

BUY
$29.95 - $46.34 $509,060 - $787,640
16,997 Added 2.71%
645,160 $20.1 Million
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $3.56 Million - $4.05 Million
88,822 Added 16.47%
628,163 $0
Q2 2018

Aug 08, 2018

BUY
$38.72 - $42.52 $6.72 Million - $7.38 Million
173,455 Added 47.41%
539,341 $0
Q1 2018

May 16, 2018

BUY
$39.4 - $47.39 $5.75 Million - $6.92 Million
145,941 Added 66.35%
365,886 $0
Q4 2017

Feb 15, 2018

BUY
$37.27 - $43.02 $8.2 Million - $9.46 Million
219,945
219,945 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.